Group | Trial 2 (2014) | Trial 3 (2015) | ||
Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | |
Control | 0.00 ± 0.00a,y | 4.30 ± 0.30a,x | 0.00 ± 0.00a,y | 4.24 ± 0.24a,x |
OA + Probiotic | 0.00 ± 0.00a,y | 0.00 ± 0.00b,y | 0.00 ± 0.00a,y | 0.00 ± 0.00b,y |